From Service to Survival: A Veteran’s Battle with Melanoma
by Mara Klecker When a bump appeared on the top of his head in 2018, retired Marine Corps Chief Warrant…
Blog - Melanoma360
11/06/2025
From Service to Survival: A Veteran’s Battle with Melanoma
by Mara Klecker When a bump appeared on the top of his head in 2018, retired Marine Corps Chief Warrant…
|
11/02/2025
From Knowledge to Action: Skin Cancer Prevention for Service Members
Introduction Members of the military experience greater morbidity and have a higher likelihood of experiencing skin cancer, and melanoma in…
11/02/2025
Immune Checkpoint Inhibition for Melanoma: A Focus on Veterans
Introduction Veterans have been shown to have a higher risk for melanoma compared to the general U.S. population due to…
|
11/02/2025
Overview of Melanoma in Veterans
Considerations Regarding Epidemiology, Risk Factors, Diagnosis, Prognosis, Survival, and Treatment Introduction Distinct health challenges affect veterans both during and after…
|
10/22/2025
SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma
Rotterdam, The Netherlands – San Diego, CA – [October 22nd] – SkylineDx today announced that results from its landmark MERLIN_001…
|
|
10/20/2025
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
Prescription Drug User Fee Act (PDUFA) target action date set for April 10, 2026 WOBURN, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) — Replimune…
|
10/14/2025
The Power of Peer Support in Melanoma Survivorship
A melanoma diagnosis can turn life upside down in an instant. While doctors focus on staging, biopsies, and treatment plans,…
|
10/07/2025
You’re Not Out of Options—What To Do After First Line Therapy Fails
Hearing that your treatment for melanoma has stopped working—or that you’ve had to stop because of side effects—can be overwhelming.…
|
09/05/2025
Advocating for Patients: Letter to the FDA on RP1 Treatment Access
Hundreds of patients, families, and friends have shared their stories with AIM at Melanoma about the urgent need for access…
09/04/2025
Hope on the Horizon: Clinical Trials & Progress in Ocular/Uveal Melanoma
AIM at Melanoma, in collaboration with its Canadian partner, the Save Your Skin Foundation, is pleased to present this informative…
Recent Posts
Apr. 19, 2026
KIMMTRAK doubles the likelihood of being alive at five years for firstline HLA-A*02:01+ patients with metastatic uveal melanoma
Apr. 10, 2026
FDA Does Not Approve RP1 in Combination with Nivolumab for Advanced Melanoma: What This Means for Patients
Apr. 07, 2026
2026 National Sunscreen Partner
Apr. 07, 2026
Young Adult Cancer & Mental Health
Apr. 02, 2026